PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA.\', \'NYU Langone Vaccine Center, NYU Grossman School of Medicine, New York, New York, USA.\', \'Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.\', \'Biohaven Pharmaceuticals, Inc., New Haven, Connecticut, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1128/mBio.00696-21
?:hasPublicationType
?:journal
  • mBio
is ?:pmid of
?:pmid
?:pmid
  • 34060334
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 4.106
?:rankingScore_hIndex
  • 71
?:title
  • Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all